I interview Drew McGregor, Vice President, Head of Medical Affairs Excellence & Sustainability at Bayer. We discuss: How to balance patient focus with commercial objectives How to reduce silos across the organisation What would pharma look like without a separate MA strategy?

Interview with Sue Giordano - Head of Field Medical at Axsome Therapeutics. We discuss: What types of data are available to medical affairs?  What is the first step when choosing the type of data to show impact (asking the right question) What else needs to be kept in mind (cross functional communication) Can you provide some examples of how data (and which type of data) can be used to show MA impact (MSLs and impact on diagnosis code examples - pilot it first before widespread...

Carlos Eid from Novartis shares his expertise on: The stakeholder engagement Journey Creating a seamless customer journey Starting with the patient Developing customer intimacy The types of data to collect along this engagement journey to assess if course correction is required.

I interview Raquel Washington, Executive Director Value Evidence Lead-Novartis US Medical. Raquel shares her experience on: - how Medical Science Liaisons (MSLs) can own their development - the steps required to progress in their careers - where to find those opportunities to grow and how to build relationships with those people in your network who will advocate for your growth. Raquel has had an incredible career in pharma so far and shares specific examples from her own pharma...

Free Newsletter on Medical Affairs Excellence: https://dynamic-salad-157.myflodesk.com/lbyatyklzm Interview with Ross Baker, VP Medical Affairs at Vistagen Therapeutics. I ask Ross: What your week looks like as a VP medical affairs for a small biotech? What are the different functions you work with? As a senior leader - how do you make decisions? What advice would you have for people listening who interact with senior leadership? Working as a VP for a company with many...

Siddharth Jain - Medical Director, Global Medical Lead, at Takeda Rare Diseases shares his experience in: - What's the biggest difference from a medical affairs perspective working in rare diseases v non rare diseases? - Is it more difficult to find and engage KOLs in rare diseases? - What's the biggest challenge working in rare diseases from an MA perspective?

I Interview Scott Baver, VP Medical Affairs and we discuss building an MA department. 3 pillars in building an MA department: Community Engagement (HCPs/Payors) - who will we engage with & why? Evidence generation - over the lifecycle - what data do we need? Communication - pubs, building materials for congresses, MSLs etc.

MSL Consultant Newsletter: Sign up Here: https://view.flodesk.com/pages/63f6032d3e1e4ad28342cc69 I interview Angelyn Solko and we discuss congress planning. Specifically: What does congress planning involve? What do you need to keep in mind with booth design? Which stakeholders within pharma are involved in congress planning? Do you have to manage the budget? What is your role at the congress? What is your role post congress? What does a congress plan look like?

I interview Stacy Conner, National MSL Director at Abbvie. We discuss: How MSLs can read the room when with KOLs Why it's important to disagree with KOLs The power of asking clarifying questions How to move KOLs to a place of understanding When to educate and when to gather insights Sign up to the MSL Consultant newsletter here: https://view.flodesk.com/pages/63f6032d3e1e4ad28342cc69

Marcus West from 60seconds shares his experience on how to develop the skill of storytelling and apply it to clinical data and KOL meetings. We discuss: Important pillars of storytelling Why emotion is so important for engaging KOLs The hero's journey and how it can be related to clinical data This episode is sponsored by 60seconds. Learn more about 60seconds here: https://60seconds.com/

MSL Interview? Book a 1:1 session here: https://mslconsultant.as.me/schedule.php or view my online MSL interview course here: https://www.mslconsultant.com/msl-interview In this interview I interview Dae Wook Lee from Novartis and we discuss: 5 Core components of Strategic Leader Framework: I.        Build a strong foundation of scientific knowledge II.      Develop a strategic mindset III.     Focus on stakeholder engagement IV.    Be a proactive problem solver V. Embrace...

Enjoy the podcast? Please leave a 5 star rating or review on wherever you listen. In this episode I interview Teresa G. Palumbo from GSK. We discuss: Account planning Formulary RWE generation

💻New Resource for KOL Engagement: Read more here: https://mslconsultant.thrivecart.com/mastering-kol-engagement/ 💻 This episode covers: Leveraging your connections to get KOL meetings Adding value to KOLs Engaging lower tier KOLs Working with emerging experts

Interested in 1:1 MSL Training? Apply here In this episode I interview Eleonora Goldberg, VP Medical Affairs. We discuss: -Difference between local, regional, global medical affairs roles -Pre-Launch Medical Affairs Masterclass How to find KOLs How to choose an institute What it is? Follow up actions of MSLs post the masterclass The outcomes of this activity

1:1 MSL Coaching - Apply here. Interview with Lori Lebson, Head of US medical Affairs at EMD Serono. We discuss: - Different stages of the product life cycle - What an ISS is - What "getting a label" means - The role of an MSL at different stages - Scientific storytelling and it's importance for MSLs to build relationships with KOLs

🔔Join my free newsletter and join over 3000 other medical affairs professionals getting insights on the MSL role 🔔 In this episode I interview Kirsten Gurtowsky MSL at Novartis. We discuss: Differences of an medical science liaison working in big pharma versus small pharma Advantages of both

FREE Video Training for Aspiring MSL. Enrol here. https://www.mslconsultant.com/aspiringmsl In this episode I share 4 tips to increase your chance of getting an MSL job.

⌛1 spot left for 1:1 MSL coaching this month. Apply here: https://www.mslconsultant.com/msl-coaching ⌛ In this episode I interview Marieke Jonkman, emotional intelligence expert and we discuss: - What is emotional intelligence - How EI can improve an MSLs ability to improve patient outcomes - How high EI could help an MSL navigate a KOL meeting that does not go as planned? - How self-reflection can be used as a tool to increase EI for MSLs and specific questions MSLs could ask...

Interview with Max Ainscough. We discuss: How MSLs can best collaborate with their commercial counterparts and demonstrate that they are a strategic partner as opposed to a support function. The best way to navigate internal politics with sales reps The specific actions MSLs can take to add more value at cross functional brand team meetings. At the end of the episode Max summarises how an MSL can maximise their capabilities.

[➡️Join my free newsletter: https://view.flodesk.com/pages/63f6032d3e1e4ad28342cc69] Sacha and I discuss:  What is a patient journey partner How he does KOL pre-call planning The types of questions he asks his KOLs How to secure follow up meetings with KOLs and add value

Maja is Global Medical Field Excellence Director and we discuss: What is MSL in-field coaching? What's the difference between coaching/training/mentoring? How often should it be? What format should it take? Maja's Linkedin: https://www.linkedin.com/in/maja-beilmann-schramm-msl-excellence-mentor/

[1:1 MSL Coaching - Learn more here: https://www.mslconsultant.com/msl-coaching] - What is modern day medical affairs? - Capabilities required to excel in medical affairs - Can medical affairs value ever be linked to prescriptions? - Can medical affairs be strategic and maintain compliance?

[1:1 MSL Training information here]  In this episode I interview VP medical affairs, Ike and we discuss: His career journey so far (Clinician to VP Medical Affairs) Diversity and the need for MSLs to stratify insights based on different patient populations Typical medical affairs launch activities

[🎉1:1 MSL Training now available - Email me at [email protected]] Can an MSL like a Linkedin post or retweet something a KOL posted?  This interview with Rina Newton, ABPI code expert answers that question. Follow Rina on Linkedin: https://www.linkedin.com/in/rinanewton/